Kayothera Inc

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Kayothera is targeting novel biology to reverse immune suppression and change the paradigm of cancer treatment by extending survival for patients with incurable cancers. We have developed first-in-class, orally available immunotherapies targeting a previously undruggable pathway that is responsible for immune suppression in solid cancers. In particular, our immunotherapeutic approach has the potential to treat soft-tissue sarcomas that currently have no effective standard of care.